ArticleCells2021

Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma.

Hitomi Sudo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.